A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer
Clinical trial NCT00423410 · COMPLETED
Trial details
- NCT number
- NCT00423410
- Sponsor
- EpiCept Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.